ClinicalTrials.Veeva

Menu

Brisk Walking Study in Nursing Home Residents

C

Clinique Mutualiste Chirurgicale de la Loire

Status

Unknown

Conditions

Autonomic Nervous System Imbalance
Physical Activity

Treatments

Behavioral: Brisk walking

Study type

Interventional

Funder types

Other

Identifiers

NCT03302923
2016-A00068-43 (Registry Identifier)
2016-08

Details and patient eligibility

About

It is well established that physical activity reduces the physiological effects of ageing. Among them, the decrease of the autonomic nervous system activity (ANS) is associated with the increase of cardiovascular events and sleep disorders occurence. It has been shown that high intensity cycle training can enhance the ANS activity by 30% in people aged of 70 years old. However, such trainings were done by old athletes used to train at intensities that could not be handled by nursing home elderly. Thus, an adapted activity such as brisk walking shall be defined to make it practicable for the many in convalescent homes. The investigators hypothesize that long term brisk walking training could lead to reactivate ANS in people living in convalescent homes.

Full description

The investigators aim to compare the effects of a 9 month brisk walking training (1 time a week or 3 times a week) on the ANS of nursing home residents.

Enrollment

100 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being over 60 years old
  • Living in a nursing home of Mutualité Française de la Loire, France
  • Being able to walk without human aid
  • Being able to speak and write French
  • Being inactive (less than 1 hours of physical activity per week)
  • Having a normal sinus rhythm
  • Being affiliated to the social welfare system
  • Signing the informed consent form

Exclusion criteria

  • Having serious balance disorders
  • Suffering from cardiac or respiratory pathologies that contraindicate physical activity
  • Serious comorbidities contraindicating physical activity
  • Diagnosed cardiac pathologies that prevent heart rate variability analysis: congestive heart failure, cardiac pacemaker, implantable cardioverter defibrillator, serious ventricular rhythm troubles, atrial fibrillation, atrial flutter.
  • Persons under legal protection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 3 patient groups

Brisk walking 1
Experimental group
Description:
1 time a week of 9 months brisk walking
Treatment:
Behavioral: Brisk walking
Brisk walking 3
Experimental group
Description:
3 times a week of 9 months brisk walking
Treatment:
Behavioral: Brisk walking
Control group
No Intervention group
Description:
No brisk walking session

Trial contacts and locations

1

Loading...

Central trial contact

David HUPIN, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems